Perspectives of farmers and tourists on agricultural abandonment in east Lesvos, Greece.

Perspectives of farmers and tourists on agricultural abandonment in east Lesvos, Greece.

Multi-stakeholder perceptions of panorama modifications are more and more acknowledged as important inputs to discussions on future panorama developments, significantly when addressing the way forward for European rural areas experiencing agricultural abandonment.

This analysis presents a case exploration of abandonment of olive plantations in east Lesvos, Greece. We carried out two units of semi-structured interviews to narrate an exploration on native farmers’ capacity and willingness to keep up the plantations, to the outcomes of a panorama choice survey undertaken with vacationers. Three farmer varieties are recognized following a cluster evaluation based mostly on attributes of particular person capacity and willingness to farm. Farmers belonging to the prevalent kind revealed low capacity and willingness and count on to additional extensify their farms.

The remaining two farmer varieties have greater willingness; they’re motivated by cultural causes, extra incessantly expressing a want to keep up their land underneath household possession, and partake in social cooperative initiatives selling practices valorizing the olive plantations. We define how these varieties work together with regional drivers of change, and partly additionally contribute to persistence of abandonment by way of constrained capacity to farm.

Abandonment doesn’t align with present panorama preferences of vacationers, who favor cultivated landscapes, components of traditionality inside constructed infrastructure and undertake nature-based actions. We focus on how excessive willingness to farm related to skilled and pluri-active types of farming could nevertheless present alternatives to keep up the cultivated panorama and synergize with (agri-)tourism demand. Our findings are corresponding to these of different European research, contributing to discussions on the way forward for its rural landscapes.

Perspectives of farmers and tourists on agricultural abandonment in east Lesvos, Greece.
Views of farmers and vacationers on agricultural abandonment in east Lesvos, Greece.

Immunophenotypic characterization, multi-lineage differentiation and growing older of zebrafish coronary heart and liver tissue-derived mesenchymal stem cells as a novel strategy in stem cell-based remedy.

Mesenchymal stem cells (MSCs) are a very good mannequin for preclinical and scientific investigations, and various sources of MSCs are topic to intensive experiments. On this examine, mesenchymal stem cells (MSCs) have been remoted from coronary heart and liver tissue of Zebrafish (Danio rerio). The flow-cytometry in addition to RT-PCR have been used to investigate the expression of a panel of cell floor markers CD44, CD90, CD31 and CD34.

AKT1 (Ab-450) Antibody

21502-100ul 100ul
EUR 302.4

AKT1 (Ab-450) Antibody

21502-50ul 50ul
EUR 224.4

AKT1 (Ab-450) Antibody

CSB-PA969941- each
EUR 402
Description: A polyclonal antibody against AKT1 (Ab-450). Recognizes AKT1 (Ab-450) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:1000, IHC:1:50-1:200, IF:1:100-1:200

AKT1 (Ab-450) Antibody

CSB-PA969941-100ul 100ul
EUR 379.2
Description: A polyclonal antibody against AKT1 (Ab-450). Recognizes AKT1 (Ab-450) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:1000, IHC:1:50-1:200, IF:1:100-1:200

anti-AKT1 (Ab-450)

LF-PA20679 100 ul
EUR 400.8
Description: Rabbit polyclonal to AKT1

Nhe I unit: 450

YRNHE1 1 vial Ask for price

mFluor™ Violet 450 acid

1140 5 mg
EUR 222

mFluor™ Violet 450 SE

1150 1 mg
EUR 222

mFluor™ Violet 450 maleimide

1600 1 mg
EUR 222

mFluor™ Violet 450 Azide

1690 1 mg
EUR 308

iFluor® 450 succinimidyl ester

71506 5 mg
EUR 781

iFluor® 450 succinimidyl ester

71556 10 mg
EUR 1301

iFluor® 450 succinimidyl ester

71026 100 ug
EUR 82

Polyclonal PACSIN2 Antibody (aa400-450)

APR17733G 0.05mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PACSIN2 (aa400-450). This antibody is tested and proven to work in the following applications:

Polyclonal SNX4 Antibody (aa438-450)

AMM07924G 0.05mg
EUR 580.8
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human SNX4 (aa438-450). This antibody is tested and proven to work in the following applications:

Polyclonal CYP1B1 Antibody (aa400-450)

APG02857G 0.05mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CYP1B1 (aa400-450). This antibody is tested and proven to work in the following applications:

Polyclonal TLR1 Antibody (aa400-450)

APR02824G 0.05mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TLR1 (aa400-450). This antibody is tested and proven to work in the following applications:

AKT1 (Ab-450) Conjugated Antibody

C21502 100ul
EUR 476.4

Bottle Centrifuge Pp 450 Ml

3141-0500 PK4
EUR 172.8

Magnetic Beads (DNA) 450 mL

P920-450 - Ask for price

mFluor™ Violet 450-VAD-FMK

13475 25 Tests
EUR 109

mFluor™ Violet 450-streptavidin conjugate

16930 100 ug
EUR 109

Polyclonal CYP24 / CYP24A1 Antibody (aa400-450)

APG02862G 0.05ml
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CYP24 / CYP24A1 (aa400-450). This antibody is tested and proven to work in the following applications:

Polypropylene Magnet Retriever 450 x 10mm

STI5212 EACH
EUR 9.6

Polyclonal TUBB / Beta Tubulin Antibody (aa401-450)

APR13866G 0.05ml
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TUBB / Beta Tubulin (aa401-450). This antibody is tested and proven to work in the following applications:

Polyclonal OLFM4 / Olfactomedin 4 Antibody (aa400-450)

APR02466G 0.05mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human OLFM4 / Olfactomedin 4 (aa400-450). This antibody is tested and proven to work in the following applications:

Annexin V-mFluor™ Violet 450 conjugate

20080 100 tests
EUR 222

Filter for Accuris Microplate Reader, 450 nm

MR9600-450 1 PC
EUR 225.9

Recombinant Salmonella envZ Protein (aa 1-450)

VAng-Wyb0428-inquire inquire Ask for price
Description: Salmonella typhi Osmolarity sensor protein EnvZ, recombinant protein.

iFluor® 450 Anti-human CD93 Antibody *VIMD2*

10930040 100 tests
EUR 547
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD93 Antibody *VIMD2*

10930041 500 tests
EUR 2051
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD95 Antibody *EOS9.1*

10950040 100 tests
EUR 547
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD95 Antibody *EOS9.1*

10950041 500 tests
EUR 2051
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD99 Antibody *HI156*

10990040 100 tests
EUR 245
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD99 Antibody *HI156*

10990041 500 tests
EUR 918
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD99 Antibody *HIT4*

10991040 100 tests
EUR 245
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD99 Antibody *HIT4*

10991041 500 tests
EUR 918
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD56 Antibody *My31*

10562040 100 tests
EUR 245
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD56 Antibody *My31*

10562041 500 tests
EUR 918
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD57 Antibody *HI57a*

10570040 100 tests
EUR 245
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD57 Antibody *HI57a*

10570041 500 tests
EUR 918
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD58 Antibody *HI58a*

10580040 100 tests
EUR 245
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD58 Antibody *HI58a*

10580041 500 tests
EUR 918
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD62 Antibody *HI62E*

10620040 100 tests
EUR 245
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD62 Antibody *HI62E*

10620041 500 tests
EUR 918
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD62l Antibody *HI62L*

10621040 100 tests
EUR 245
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD62l Antibody *HI62L*

10621041 500 tests
EUR 918
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD62p Antibody *HI62P*

10622040 100 tests
EUR 245
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD62p Antibody *HI62P*

10622041 500 tests
EUR 918
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD64 Antibody *10.1*

10640040 100 tests
EUR 245
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD64 Antibody *10.1*

10640041 500 tests
EUR 918
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD69 Antibody *FN50*

10690040 100 tests
EUR 547
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD69 Antibody *FN50*

10690041 500 tests
EUR 2051
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD82 Antibody *C33*

10820040 100 tests
EUR 547
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD82 Antibody *C33*

10820041 500 tests
EUR 2051
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD84 Antibody *CD84.1.21*

10840040 100 tests
EUR 547
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD84 Antibody *CD84.1.21*

10840041 500 tests
EUR 2051
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD85 Antibody *17G10.2*

10850040 100 tests
EUR 547
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD85 Antibody *17G10.2*

10850041 500 tests
EUR 2051
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD87 Antibody *VIM5*

10870040 100 tests
EUR 547
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD87 Antibody *VIM5*

10870041 500 tests
EUR 2051
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD71 Antibody *HI160*

10710040 100 tests
EUR 245
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD71 Antibody *HI160*

10710041 500 tests
EUR 918
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD71 Antibody *HI166*

10711040 100 tests
EUR 245
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD71 Antibody *HI166*

10711041 500 tests
EUR 918
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD72 Antibody *3F3*

10720040 100 tests
EUR 547
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD72 Antibody *3F3*

10720041 500 tests
EUR 2051
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD73 Antibody *AD2*

10730040 100 tests
EUR 547
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD73 Antibody *AD2*

10730041 500 tests
EUR 2051
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-mouse CD197 Antibody *4B12*

11970040 100 tests
EUR 547
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-mouse CD197 Antibody *4B12*

11970041 500 tests
EUR 2051
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD203c Antibody *NP4D6*

12030040 100 tests
EUR 547
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD203c Antibody *NP4D6*

12030041 500 tests
EUR 2051
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD205 Antibody *HD30*

12050040 100 tests
EUR 547
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD205 Antibody *HD30*

12050041 500 tests
EUR 2051
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD209 Antibody *UW60.1*

12090040 100 tests
EUR 547
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD209 Antibody *UW60.1*

12090041 500 tests
EUR 2051
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD229 Antibody *HLy9.25*

12290040 100 tests
EUR 547
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD229 Antibody *HLy9.25*

12290041 500 tests
EUR 2051
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD231 Antibody *B2D*

12310040 100 tests
EUR 547
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD231 Antibody *B2D*

12310041 500 tests
EUR 2051
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD235 Antibody *HI264*

12350040 100 tests
EUR 245
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD235 Antibody *HI264*

12350041 500 tests
EUR 918
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD235 Antibody *HIR2*

12351040 100 tests
EUR 245
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD235 Antibody *HIR2*

12351041 500 tests
EUR 918
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD243 Antibody *UIC2*

12430040 100 tests
EUR 547
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD243 Antibody *UIC2*

12430041 500 tests
EUR 2051
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD253 Antibody *2E5*

12530040 100 tests
EUR 547
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD253 Antibody *2E5*

12530041 500 tests
EUR 2051
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD123 Antibody *12H7*

11231040 100 tests
EUR 245
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD123 Antibody *12H7*

11231041 500 tests
EUR 918
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD133 Antibody *293C3*

11330040 100 tests
EUR 607
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD133 Antibody *293C3*

11330041 500 tests
EUR 2280
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD135 Antibody *BV10A4*

11350040 100 tests
EUR 547
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD135 Antibody *BV10A4*

11350041 500 tests
EUR 2051
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD138 Antibody *MI15*

11380040 100 tests
EUR 245
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD138 Antibody *MI15*

11380041 500 tests
EUR 918
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD140a Antibody *16A1*

11400040 100 tests
EUR 547
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD140a Antibody *16A1*

11400041 500 tests
EUR 2051
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD140b Antibody *18A2*

11401040 100 tests
EUR 547
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD140b Antibody *18A2*

11401041 500 tests
EUR 2051
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD162 Antibody *TC2*

11620040 100 tests
EUR 547
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD162 Antibody *TC2*

11620041 500 tests
EUR 2051
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD164 Antibody *67D2*

11640040 100 tests
EUR 547
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD164 Antibody *67D2*

11640041 500 tests
EUR 2051
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD165 Antibody *SN2*

11650040 100 tests
EUR 547
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD165 Antibody *SN2*

11650041 500 tests
EUR 2051
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD167a Antibody *51D6*

11670040 100 tests
EUR 547
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD167a Antibody *51D6*

11670041 500 tests
EUR 2051
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD172 Antibody *B4B6*

11721040 100 tests
EUR 547
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD172 Antibody *B4B6*

11721041 500 tests
EUR 2051
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD152 Antibody *BN13*

11520040 100 tests
EUR 245
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD152 Antibody *BN13*

11520041 500 tests
EUR 918
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD160 Antibody *BY55*

11600040 100 tests
EUR 547
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD160 Antibody *BY55*

11600041 500 tests
EUR 2051
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD109 Antibody *W7C5*

11090040 100 tests
EUR 547
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD109 Antibody *W7C5*

11090041 500 tests
EUR 2051
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD111 Antibody *R1.302*

11110040 100 tests
EUR 547
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD111 Antibody *R1.302*

11110041 500 tests
EUR 2051
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD112 Antibody *R2.525*

11120040 100 tests
EUR 547
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn

iFluor® 450 Anti-human CD112 Antibody *R2.525*

11120041 500 tests
EUR 2051
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn
  1. Within the following, alizarin pink, oil red-O and toluidine blue staining have been carried out to judge the multi-lineage differentiation of zebrafish coronary heart and liver tissue-derived MSCs. Subsequently, the gene and protein expression of Oct4, Sox2 and Nanog as pluri

    -potent markers have been analyzed by RT-PCR and western blotting, respectively.

As well as, MTT assay was used for cell proliferation potential and inhabitants doubling time (PDT) evaluation. Additionally, the growing older of cells was investigated by β-galactosidase exercise assay. The outcomes confirmed that, like different MSCs, zebrafish coronary heart and liver tissue-derived MSCs have been constructive for mesenchymal, adverse for hematopoietic markers and expressed pluripotent markers Oct4, Sox2 and Nanog. Furthermore, these cells have been differentiated to osteocyte, adipocyte, and chondrocyte lineages following directed differentiation. It was discovered that PDT of zebrafish coronary heart and liver tissue-derived MSCs have been 50.67 and 46.61 h, respectively.

These cells had considerably extra speedy progress on day 4. Our outcomes present that zebrafish coronary heart and liver tissue-derived MSCs exhibited typical MSC traits together with fibroblast morphology, multi-lineage differentiation capability, pluriefficiency potential and expression of a typical set of basic MSC floor markers.

Safety and Activity of Metronomic Temozolomide in Second-Line Treatment of Advanced Neuroendocrine Neoplasms.

Safety and Activity of Metronomic Temozolomide in Second-Line Treatment of Advanced Neuroendocrine Neoplasms.

Platinum-based chemotherapy is the mainstay of front-line therapy of sufferers affected by pluri-metastatic intermediate/excessive grade NeuroEndocrine Neoplasms (NENs). Nevertheless, there aren’t any commonplace second-line remedies at illness development.

Earlier scientific experiences have evidenced that temozolomide (TMZ), an oral analog of dacarbazine, is lively in opposition to NENs at commonplace doses of 150 to 200 mg/mq per day on days 1 to five of a 28-day cycle, even when a major treatment-related toxicity is reported.

METHODS

Metastatic NENs sufferers had been handled on the ENETS (European NeuroEndocrine Tumor Society) heart of excellence of Naples (Italy), from 2014 to 2017 with a second-line various metronomic schedule of TMZ, 75 mg/m2per os “one week on/one week off”. Toxicity was graded with NCI-CTC standards v4.0; goal responses with RECIST v1.1 and efficiency standing (PS) in accordance with ECOG.

Twenty-six consecutive sufferers had been handled. Median age was 65.5 years. The predominant main organs had been pancreas and lung. Grading was G2 in 11 sufferers, G3 in 15. Greater than half of sufferers had a PS 2 (15 vs. 11 with PS 1). The median time-on-temozolomide remedy was 12.2 months (95% CI: 11.4-19.6). No G3/G4 toxicities had been registered.

Full response was obtained in 1 affected person, partial response in 4, steady illness in 19 (illness management price: 92.3%), and progressive illness in 2. The median total survival from TMZ begin was 28.Three months. PS improved in 73% of sufferers.Metronomic TMZ is an acceptable therapy for G2 and G3 NENs significantly in PS 2 sufferers. Potential and bigger trials are wanted to verify these outcomes.

Safety and Activity of Metronomic Temozolomide in Second-Line Treatment of Advanced Neuroendocrine Neoplasms.
Security and Exercise of Metronomic Temozolomide in Second-Line Remedy of Superior Neuroendocrine Neoplasms.

Would ivermectin for malaria management be useful in onchocerciasis-endemic areas?

There may be accumulating proof supporting using ivermectin as a malaria management software. Latest findings from the repeat ivermectin mass drug administrations for management of malaria trial demonstrated a diminished incidence of malaria in villages which obtained repeated ivermectin mass drug administration (MDA; six doses) in comparison with those that had just one spherical of ivermectin.

EEF1A2 siRNA

20-abx901643
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

EEF1A2 Peptide

43-205P 0.1 mg
EUR 405.6

EEF1A2 antibody

70R-3046 50 ug
EUR 560.4
Description: Rabbit polyclonal EEF1A2 antibody raised against the middle region of EEF1A2

EEF1A2 Antibody

AF6618 100ul
EUR 420

EEF1A2 antibody

70R-17001 50 ul
EUR 522
Description: Rabbit polyclonal EEF1A2 antibody

EEF1A2 Antibody

45965-100ul 100ul
EUR 302.4

EEF1A2 Antibody

45965-50ul 50ul
EUR 224.4

EEF1A2 Antibody

ABD9493 100 ug
EUR 525.6

EEF1A2 Antibody

DF9493 200ul
EUR 420

EEF1A2 Antibody

1-CSB-PA007412ESR1HU
  • EUR 266.40
  • EUR 402.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against EEF1A2. Recognizes EEF1A2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200

EEF1A2 Antibody

1-CSB-PA007412ESR2HU
  • EUR 266.40
  • EUR 402.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against EEF1A2. Recognizes EEF1A2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200

EEF1A2 Antibody

1-CSB-PA007412GA01HU
  • EUR 716.40
  • EUR 399.60
  • 150ul
  • 50ul
Description: A polyclonal antibody against EEF1A2. Recognizes EEF1A2 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC

EEF1A2 Antibody

R34872-100UG 100 ug
EUR 339.15
Description: Additional name(s) for this target protein: Eukaryotic translation elongation factor 1 alpha 2, EEF1AL, EF-1-alpha-2; EEF1A2

EEF1A1 / EEF1A2 / EEF1A1P5 Antibody

20-abx327705
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

EEF1A1/EEF1A2/EEF1A1P5 Antibody

1-CSB-PA005918
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EEF1A1/EEF1A2/EEF1A1P5. Recognizes EEF1A1/EEF1A2/EEF1A1P5 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000

EEF1A2 Rabbit pAb

A2473-100ul 100 ul
EUR 369.6

EEF1A2 Rabbit pAb

A2473-200ul 200 ul
EUR 550.8

EEF1A2 Rabbit pAb

A2473-20ul 20 ul
EUR 219.6

EEF1A2 Rabbit pAb

A2473-50ul 50 ul
EUR 267.6

EEF1A2 Rabbit pAb

A7327-100ul 100 ul
EUR 369.6

EEF1A2 Rabbit pAb

A7327-200ul 200 ul
EUR 550.8

EEF1A2 Rabbit pAb

A7327-20ul 20 ul
EUR 219.6

EEF1A2 Rabbit pAb

A7327-50ul 50 ul
EUR 267.6

Human EEF1a2 Protein

20-abx650911
  • EUR 693.60
  • EUR 309.60
  • EUR 2064.00
  • EUR 828.00
  • EUR 510.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

anti- EEF1A2 antibody

FNab02642 100µg
EUR 606.3
Description: Antibody raised against EEF1A2

EEF1A2 Blocking Peptide

33R-9588 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of EEF1A2 antibody, catalog no. 70R-3046

EEF1A2 Blocking Peptide

DF9493-BP 1mg
EUR 234

Recombinant Human EEF1A2

P0565 100ug
EUR 626.83
Description: Recombinant Human protein for EEF1A2

EEF1A2 Conjugated Antibody

C45965 100ul
EUR 476.4

EEF1A2 ELISA KIT|Human

EF009296 96 Tests
EUR 826.8

Rat EEF1A2 shRNA Plasmid

20-abx984646
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Human EEF1A2 shRNA Plasmid

20-abx951333
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Mouse EEF1A2 shRNA Plasmid

20-abx970114
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

EEF1A2 Recombinant Protein (Rat)

RP199082 100 ug Ask for price

EEF1A2 Recombinant Protein (Human)

RP010195 100 ug Ask for price

EEF1A2 Recombinant Protein (Mouse)

RP130898 100 ug Ask for price

Eef1a2 ORF Vector (Rat) (pORF)

ORF066362 1.0 ug DNA
EUR 607.2

EEF1A2 ORF Vector (Human) (pORF)

ORF003399 1.0 ug DNA
EUR 114

Eef1a2 ORF Vector (Mouse) (pORF)

ORF043634 1.0 ug DNA
EUR 607.2

eEF1A2 binding protein Polyclonal Antibody

ABP57282-003ml 0.03ml
EUR 189.6
Description: A polyclonal antibody for detection of eEF1A2 binding protein from Human, Mouse, Rat, Pig. This eEF1A2 binding protein antibody is for WB, IHC-P. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen recombinant protein

eEF1A2 binding protein Polyclonal Antibody

ABP57282-01ml 0.1ml
EUR 346.8
Description: A polyclonal antibody for detection of eEF1A2 binding protein from Human, Mouse, Rat, Pig. This eEF1A2 binding protein antibody is for WB, IHC-P. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen recombinant protein

eEF1A2 binding protein Polyclonal Antibody

ABP57282-02ml 0.2ml
EUR 496.8
Description: A polyclonal antibody for detection of eEF1A2 binding protein from Human, Mouse, Rat, Pig. This eEF1A2 binding protein antibody is for WB, IHC-P. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen recombinant protein

eEF1A2 binding protein Polyclonal Antibody

ES8281-100ul 100ul
EUR 334.8
Description: A Rabbit Polyclonal antibody against eEF1A2 binding protein from Human/Rat/Mouse/Pig. This antibody is tested and validated for WB, ELISA, IHC

eEF1A2 binding protein Polyclonal Antibody

ES8281-50ul 50ul
EUR 248.4
Description: A Rabbit Polyclonal antibody against eEF1A2 binding protein from Human/Rat/Mouse/Pig. This antibody is tested and validated for WB, ELISA, IHC

eEF1A2 binding protein Polyclonal Antibody

EA194-100ul 100ul
EUR 334.8
Description: A Rabbit Polyclonal antibody against eEF1A2 binding protein from Human/ Rat/ Mouse/ Pg. This antibody is tested and validated for WB, ELISA, IHC

eEF1A2 binding protein Polyclonal Antibody

EA194-50ul 50ul
EUR 248.4
Description: A Rabbit Polyclonal antibody against eEF1A2 binding protein from Human/ Rat/ Mouse/ Pg. This antibody is tested and validated for WB, ELISA, IHC

eEF1A2 binding protein Polyclonal Antibody

EA252-100ul 100ul
EUR 334.8
Description: A Rabbit Polyclonal antibody against eEF1A2 binding protein from Human/ Rat/ Mouse/ Pig. This antibody is tested and validated for WB, ELISA, IHC

eEF1A2 binding protein Polyclonal Antibody

EA252-50ul 50ul
EUR 248.4
Description: A Rabbit Polyclonal antibody against eEF1A2 binding protein from Human/ Rat/ Mouse/ Pig. This antibody is tested and validated for WB, ELISA, IHC

Eef1a2 sgRNA CRISPR Lentivector set (Rat)

K6923401 3 x 1.0 ug
EUR 406.8

EEF1A2 sgRNA CRISPR Lentivector set (Human)

K0655101 3 x 1.0 ug
EUR 406.8

Eef1a2 sgRNA CRISPR Lentivector set (Mouse)

K3721701 3 x 1.0 ug
EUR 406.8

Eef1a2 3'UTR GFP Stable Cell Line

TU155610 1.0 ml Ask for price

EEF1A2 3'UTR GFP Stable Cell Line

TU056615 1.0 ml
EUR 1672.8

Eef1a2 3'UTR GFP Stable Cell Line

TU253788 1.0 ml Ask for price

EEF1A2 Protein Vector (Rat) (pPM-C-HA)

PV265448 500 ng
EUR 723.6

EEF1A2 Protein Vector (Rat) (pPB-C-His)

PV265446 500 ng
EUR 723.6

EEF1A2 Protein Vector (Rat) (pPB-N-His)

PV265447 500 ng
EUR 723.6

EEF1A2 Protein Vector (Rat) (pPM-C-His)

PV265449 500 ng
EUR 723.6

EEF1A2 Protein Vector (Human) (pPM-C-HA)

PV013595 500 ng
EUR 394.8

EEF1A2 Protein Vector (Mouse) (pPM-C-HA)

PV174536 500 ng
EUR 723.6

EEF1A2 Protein Vector (Human) (pPB-C-His)

PV013593 500 ng
EUR 394.8

EEF1A2 Protein Vector (Human) (pPB-N-His)

PV013594 500 ng
EUR 394.8

EEF1A2 Protein Vector (Human) (pPM-C-His)

PV013596 500 ng
EUR 394.8

EEF1A2 Protein Vector (Mouse) (pPB-C-His)

PV174534 500 ng
EUR 723.6

EEF1A2 Protein Vector (Mouse) (pPB-N-His)

PV174535 500 ng
EUR 723.6

EEF1A2 Protein Vector (Mouse) (pPM-C-His)

PV174537 500 ng
EUR 723.6

EEF1A2 3'UTR Luciferase Stable Cell Line

TU006615 1.0 ml
EUR 1672.8

Eef1a2 3'UTR Luciferase Stable Cell Line

TU105610 1.0 ml Ask for price

Eef1a2 3'UTR Luciferase Stable Cell Line

TU203788 1.0 ml Ask for price

Eef1a2 sgRNA CRISPR Lentivector (Rat) (Target 1)

K6923402 1.0 ug DNA
EUR 184.8

Eef1a2 sgRNA CRISPR Lentivector (Rat) (Target 2)

K6923403 1.0 ug DNA
EUR 184.8

Eef1a2 sgRNA CRISPR Lentivector (Rat) (Target 3)

K6923404 1.0 ug DNA
EUR 184.8

EEF1A2 sgRNA CRISPR Lentivector (Human) (Target 1)

K0655102 1.0 ug DNA
EUR 184.8

EEF1A2 sgRNA CRISPR Lentivector (Human) (Target 2)

K0655103 1.0 ug DNA
EUR 184.8

EEF1A2 sgRNA CRISPR Lentivector (Human) (Target 3)

K0655104 1.0 ug DNA
EUR 184.8

Eef1a2 sgRNA CRISPR Lentivector (Mouse) (Target 1)

K3721702 1.0 ug DNA
EUR 184.8

Eef1a2 sgRNA CRISPR Lentivector (Mouse) (Target 2)

K3721703 1.0 ug DNA
EUR 184.8

Eef1a2 sgRNA CRISPR Lentivector (Mouse) (Target 3)

K3721704 1.0 ug DNA
EUR 184.8

EEF1A2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV678607 1.0 ug DNA
EUR 818.4

EEF1A2 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV678611 1.0 ug DNA
EUR 818.4

EEF1A2 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV678612 1.0 ug DNA
EUR 818.4

Rat Elongation factor 1- alpha 2, Eef1a2 ELISA KIT

ELI-09300r 96 Tests
EUR 1063.2

Human Elongation Factor 1 Alpha 2 (EEF1A2) ELISA Kit

abx387052-96tests 96 tests
EUR 1093.2

Human Elongation factor 1- alpha 2, EEF1A2 ELISA KIT

ELI-09299h 96 Tests
EUR 988.8

Mouse Elongation factor 1- alpha 2, Eef1a2 ELISA KIT

ELI-32725m 96 Tests
EUR 1038

Rabbit Elongation factor 1- alpha 2, EEF1A2 ELISA KIT

ELI-09609Ra 96 Tests
EUR 1113.6

Bovine Elongation factor 1- alpha 2, EEF1A2 ELISA KIT

ELI-26629b 96 Tests
EUR 1113.6

Eef1a2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)

K6923405 3 x 1.0 ug
EUR 451.2

EEF1A2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)

K0655105 3 x 1.0 ug
EUR 451.2

Eef1a2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)

K3721705 3 x 1.0 ug
EUR 451.2

Eukaryotic Translation Elongation Factor 1 Alpha 2 (EEF1A2) Antibody

abx232642-100ug 100 ug
EUR 577.2

Eukaryotic Translation Elongation Factor 1 Alpha 2 (EEF1A2) Antibody

20-abx225152
  • EUR 444.00
  • EUR 727.20
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 50 ul

Eukaryotic Translation Elongation Factor 1 Alpha 2 (EEF1A2) Antibody

20-abx215074
  • EUR 510.00
  • EUR 410.40
  • 100 ug
  • 50 ug

Eukaryotic Translation Elongation Factor 1 Alpha 2 (EEF1A2) Antibody

20-abx321863
  • EUR 526.80
  • EUR 393.60
  • 100 ul
  • 50 ul

Eukaryotic Translation Elongation Factor 1 Alpha 2 (EEF1A2) Antibody

20-abx321864
  • EUR 526.80
  • EUR 393.60
  • 100 ul
  • 50 ul

Eukaryotic Translation Elongation Factor 1 Alpha 2 (EEF1A2) Antibody

20-abx112350
  • EUR 878.40
  • EUR 477.60
  • 150 ul
  • 50 ul

Eukaryotic Translation Elongation Factor 1 Alpha 2 (EEF1A2) Antibody

abx026885-400ul 400 ul
EUR 627.6

Eukaryotic Translation Elongation Factor 1 Alpha 2 (EEF1A2) Antibody

abx026885-80l 80 µl
EUR 343.2

Eukaryotic Translation Elongation Factor 1 Alpha 2 (EEF1A2) Antibody

20-abx126892
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Eukaryotic Translation Elongation Factor 1 Alpha 2 (EEF1A2) Antibody

abx431222-200ul 200 ul
EUR 460.8

Recombinant Eukaryotic Translation Elongation Factor 1 Alpha 2 (EEF1a2)

4-RPF021Hu01
  • EUR 496.32
  • EUR 256.80
  • EUR 1531.20
  • EUR 590.40
  • EUR 1060.80
  • EUR 408.00
  • EUR 3648.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Eukaryotic Translation Elongation Factor 1 Alpha 2 expressed in: E.coli

Eef1a2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)

K6923406 1.0 ug DNA
EUR 200.4

Eef1a2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)

K6923407 1.0 ug DNA
EUR 200.4

Eef1a2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)

K6923408 1.0 ug DNA
EUR 200.4

EEF1A2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)

K0655106 1.0 ug DNA
EUR 200.4

EEF1A2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)

K0655107 1.0 ug DNA
EUR 200.4

EEF1A2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)

K0655108 1.0 ug DNA
EUR 200.4

Eef1a2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1)

K3721706 1.0 ug DNA
EUR 200.4

Eef1a2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)

K3721707 1.0 ug DNA
EUR 200.4

Eef1a2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3)

K3721708 1.0 ug DNA
EUR 200.4

EEF1A2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA)

LV678608 1.0 ug DNA
EUR 818.4

EEF1A2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

LV678609 1.0 ug DNA
EUR 888

EEF1A2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV678610 1.0 ug DNA
EUR 888

Polyclonal Phospho-Ser358 Eukaryotic Elongation Factor 1 alpha 2 (eEF1A2) Antibody

APR03408G 0.1ml
EUR 633.6
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Phospho-Ser358 Eukaryotic Elongation Factor 1 alpha 2 (eEF1A2) . This antibody is tested and proven to work in the following applications:

Eef1a1/ Rat Eef1a1 ELISA Kit

ELI-31541r 96 Tests
EUR 1063.2

EEF1A1 siRNA

20-abx914974
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

EEF1A1 siRNA

20-abx914975
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

EEF1A1 siRNA

20-abx901642
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

EEF1A1 Rabbit pAb

A0974-100ul 100 ul
EUR 369.6

EEF1A1 Rabbit pAb

A0974-200ul 200 ul
EUR 550.8

EEF1A1 Rabbit pAb

A0974-20ul 20 ul
EUR 219.6

EEF1A1 Rabbit pAb

A0974-50ul 50 ul
EUR 267.6

EEF1A1 Rabbit pAb

A0831-100ul 100 ul
EUR 369.6

EEF1A1 Rabbit pAb

A0831-200ul 200 ul
EUR 550.8

EEF1A1 Rabbit pAb

A0831-20ul 20 ul Ask for price

EEF1A1 Rabbit pAb

A0831-50ul 50 ul Ask for price

eEF1A1 Rabbit mAb

A11545-100ul 100 ul
EUR 492

eEF1A1 Rabbit mAb

A11545-200ul 200 ul
EUR 685.2

eEF1A1 Rabbit mAb

A11545-20ul 20 ul
EUR 265.2

eEF1A1 Rabbit mAb

A11545-50ul 50 ul
EUR 344.4

EEF1A1 Rabbit pAb

A17857-100ul 100 ul
EUR 369.6

EEF1A1 Rabbit pAb

A17857-200ul 200 ul
EUR 550.8

EEF1A1 Rabbit pAb

A17857-20ul 20 ul
EUR 219.6

EEF1A1 Rabbit pAb

A17857-50ul 50 ul
EUR 267.6

EEF1A1 antibody

70R-1029 100 ug
EUR 452.4
Description: Rabbit polyclonal EEF1A1 antibody raised against the C terminal of EEF1A1

EEF1A1 antibody

70R-17000 50 ul
EUR 522
Description: Rabbit polyclonal EEF1A1 antibody

EEF1A1 Antibody

32103-100ul 100ul
EUR 302.4

eEF1A1 Antibody

49856-100ul 100ul
EUR 399.6

eEF1A1 Antibody

49856-50ul 50ul
EUR 286.8

EEF1A1 Antibody

ABD6156 100 ug
EUR 525.6

EEF1A1 Antibody

DF6156 200ul
EUR 420

EEF1A1 Antibody

1-CSB-PA007409GA01HU
  • EUR 716.40
  • EUR 399.60
  • 150ul
  • 50ul
Description: A polyclonal antibody against EEF1A1. Recognizes EEF1A1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF

EEF1A1 Antibody

1-CSB-PA007409LA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EEF1A1. Recognizes EEF1A1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200

EEF1A1/2 Antibody

F54864-0.08ML 0.08 ml
EUR 140.25
Description: EEF1A1 is an isoform of the alpha subunit of the elongation factor-1 complex, which is responsible for the enzymatic delivery of aminoacyl tRNAs to the ribosome. This isoform (alpha 1) is expressed in brain, placenta, lung, liver, kidney, and pancreas, and the other isoform (alpha 2) is expressed in brain, heart and skeletal muscle. This isoform is identified as an autoantigen in 66% of patients with Felty syndrome.

EEF1A1/2 Antibody

F54864-0.4ML 0.4 ml
EUR 322.15
Description: EEF1A1 is an isoform of the alpha subunit of the elongation factor-1 complex, which is responsible for the enzymatic delivery of aminoacyl tRNAs to the ribosome. This isoform (alpha 1) is expressed in brain, placenta, lung, liver, kidney, and pancreas, and the other isoform (alpha 2) is expressed in brain, heart and skeletal muscle. This isoform is identified as an autoantigen in 66% of patients with Felty syndrome.

EEF1A1/2 Antibody

F54865-0.08ML 0.08 ml
EUR 140.25
Description: EEF1A1 is an isoform of the alpha subunit of the elongation factor-1 complex, which is responsible for the enzymatic delivery of aminoacyl tRNAs to the ribosome. This isoform (alpha 1) is expressed in brain, placenta, lung, liver, kidney, and pancreas, and the other isoform (alpha 2) is expressed in brain, heart and skeletal muscle. This isoform is identified as an autoantigen in 66% of patients with Felty syndrome.

EEF1A1/2 Antibody

F54865-0.4ML 0.4 ml
EUR 322.15
Description: EEF1A1 is an isoform of the alpha subunit of the elongation factor-1 complex, which is responsible for the enzymatic delivery of aminoacyl tRNAs to the ribosome. This isoform (alpha 1) is expressed in brain, placenta, lung, liver, kidney, and pancreas, and the other isoform (alpha 2) is expressed in brain, heart and skeletal muscle. This isoform is identified as an autoantigen in 66% of patients with Felty syndrome.

EEF1A1 protein (His tag)

80R-3746 100 ug
EUR 418.8
Description: Purified recombinant EEF1A1 protein (His tag)

Human EEF1A1 ELISA Kit

ELA-E11476h 96 Tests
EUR 988.8

EEF1A1 ELISA KIT|Human

EF003718 96 Tests
EUR 826.8

Eef1a1 ORF Vector (Rat) (pORF)

ORF066361 1.0 ug DNA
EUR 607.2

anti- EEF1A1 antibody

FNab02641 100µg
EUR 658.5
Description: Antibody raised against EEF1A1

Rat EEF1A1 shRNA Plasmid

20-abx987742
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Human EEF1A1 Antibody

35679-05111 150 ug
EUR 313.2

Human EEF1A1P5 ELISA KIT

ELI-27624h 96 Tests
EUR 988.8

A number of different research investigating the advantages of ivermectin for malaria functions are ongoing/deliberate.Whereas ivermectin MDA provides promising views within the combat in opposition to malaria, we spotlight the added advantages and anticipated challenges of conducting future research in onchocerciasis-endemic areas, that are confronted with a considerable illness burden together with onchocerciasis-associated epilepsy.

Rising the frequency of ivermectin MDA in such locations could scale back the burden of each malaria and onchocerciasis, and permit for extra entomological investigations on each the Anopheles mosquitoes and the blackflies.

Upfront, acceptability and feasibility research are wanted to evaluate the endorsement by the native populations, in addition to the programmatic feasibility of implementing ivermectin MDA a number of occasions a yr.Onchocerciasis-endemic websites would doubly profit from ivermectin MDA interventions, as these will alleviate onchocerciasis-associated morbidity and mortality, whereas doubtlessly curbing malaria transmission. Involving onchocerciasis applications and different related stakeholders within the malaria/ivermectin analysis agenda would foster the implementation of pluri-annual MDA in goal communities.

The ZT Biopolymer: A Self-Assembling Protein Scaffold for Stem Cell Applications.

The ZT Biopolymer: A Self-Assembling Protein Scaffold for Stem Cell Applications.

The event of cell tradition programs for the naturalistic propagation, self-renewal and differentiation of cells ex vivo is a excessive purpose of molecular engineering. Regardless of vital success in recent times, the excessive value of up-scaling cultures, the necessity for xeno-free tradition situations, and the diploma of mimicry of the natural extracellular matrix attainable in vitro utilizing designer substrates proceed to pose obstacles to the interpretation of cell-based technologies.

On this regard, the ZT biopolymer is a protein-based, steady, scalable, and economical cell substrate of excessive promise. ZT relies on the naturally occurring meeting of two human proteins: titin-Z1Z2 and telethonin. These protein constructing blocks are strong scaffolds that may be conveniently functionalized with full-length proteins and bioactive peptidic motifs by genetic manipulation, previous to self-assembly.

The polymer is, thereby, totally encodable. Functionalized variations of the ZT polymer have been proven to efficiently maintain the long-term culturing of human embryonic stem cells (hESCs), human induced pluripotent stem cells (hiPSCs), and murine mesenchymal stromal cells (mMSCs).

Pluripotency of hESCs and hiPSCs was retained for the longest interval assayed (four months). Outcomes level to the big potential of the ZT system for the creation of a modular, pluri-functional biomaterial for cell-based purposes.

The ZT Biopolymer: A Self-Assembling Protein Scaffold for Stem Cell Applications.

Maxwell®: An Unsupervised Studying Method for 5P Medication.

Within the 5P medication (Customized, Preventive, Participative, Predictive and Pluri-expert), the final pattern is to course of information by displacing the barycenter of the data from hospital centered programs to the affected person centered ones by his private medical information.

EGF

90201-3 1000 µg
EUR 335
Description: Human Epidermal Growth Factor (GenBank Accession No. NM_001963), a.a. 971- 1023, MW=6.2 kDa, expressed in an E. coli expression system.

EGF

MO15063 100 ug
EUR 490.8

EGF

LF-PR003 200 ug
EUR 170.4
Description: EGF protein

EGF

PR27006 500 ug
EUR 381.6

EGF

PR27009 500 ug
EUR 381.6

EGF

E13-007-1 10μg
EUR 99.6

EGF

E13-007-2 50μg
EUR 138

EGF

E21-029 10ug
EUR 411.6

rHu EGF

AK8327-0100 100µg Ask for price

rHu EGF

AK8327-0500 500µg Ask for price

rHu EGF

AK8327-1000 1mg Ask for price

EGF, Rat

HY-P7092 50ug
EUR 253.2

EGF siRNA

20-abx915073
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

EGF siRNA

20-abx915074
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

EGF siRNA

20-abx901657
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

Mouse EGF

90200-1 100 µg
EUR 85
Description: Mouse Epidermal Growth Factor (GenBank Accession No. NM_010113), a.a. 977- 1029, MW=6.0 kDa, expressed in an E. coli expression system.

Mouse EGF

90200-2 500 µg_x000D_
EUR 210
Description: Mouse Epidermal Growth Factor (GenBank Accession No. NM_010113), a.a. 977- 1029, MW=6.0 kDa, expressed in an E. coli expression system.

Mouse EGF

90200-3 1000 µg
EUR 320
Description: Mouse Epidermal Growth Factor (GenBank Accession No. NM_010113), a.a. 977- 1029, MW=6.0 kDa, expressed in an E. coli expression system.

EGF Mouse

P2558-.1 100 µg
EUR 129.6

EGF Mouse

P2558-.5 500 µg
EUR 240

EGF Mouse

P2558-1 1 mg
EUR 373.2

EGF, Mouse

HY-P7067 100ug
EUR 224.4

EGF, Human

HY-P7109 50ug
EUR 129.6

EGF Pichia

PR27007 500 ug
EUR 381.6

EGF Protein

abx169012-1mg 1 mg
EUR 543.6

EGF protein

30R-1056 100 ug
EUR 321.6
Description: Purified recombinant Human EGF protein

EGF protein

30R-2331 500 ug
EUR 380.4
Description: Purified recombinant Human EGF protein

EGF protein

30R-2332 500 ug
EUR 390
Description: Purified recombinant Mouse EGF protein

EGF protein

30R-2333 20 ug
EUR 252
Description: Purified recombinant Rat EGF protein

EGF protein

30R-AE003 1 mg
EUR 457.2
Description: Purified recombinant Human EGF protein

EGF protein

30R-AE004 100 ug
EUR 159.6
Description: Purified recombinant Human EGF protein

EGF protein

30R-AE025 100 ug
EUR 327.6
Description: Purified recombinant Human EGF protein

EGF Protein

abx069820-1mg 1 mg
EUR 1296

EGF antibody

10-E39A 500 ug
EUR 679.2
Description: Mouse monoclonal EGF antibody

EGF antibody

10R-2038 100 ul
EUR 483.6
Description: Mouse monoclonal EGF antibody

EGF antibody

10R-2176 100 ul
EUR 483.6
Description: Mouse monoclonal EGF antibody

EGF antibody

10R-2969 100 ug
EUR 318
Description: Mouse monoclonal EGF antibody

EGF antibody

10R-2985 100 ug
EUR 318
Description: Mouse monoclonal EGF antibody

EGF antibody

10R-7766 500 ug
EUR 678
Description: Mouse monoclonal EGF antibody

EGF antibody

20C-CR1085GP 100 ug
EUR 177.6
Description: Goat polyclonal EGF antibody

EGF antibody

20R-1772 100 ug
EUR 807.6
Description: Rabbit polyclonal EGF antibody

EGF Antibody

BF0066 200ul
EUR 540

EGF antibody

38447-100ul 100ul
EUR 302.4

EGF antibody

70R-EG001 50 ug
EUR 327.6
Description: Affinity purified Goat polyclonal EGF antibody

EGF antibody

70R-ER012 50 ug
EUR 327.6
Description: Affinity purified Rabbit polyclonal EGF antibody

EGF Antibody

AF5148 200ul
EUR 420

EGF antibody

70-ER40 50 ug
EUR 340.8
Description: Affinity purified Rabbit polyclonal EGF antibody

EGF Antibody

49545-100ul 100ul
EUR 399.6

EGF Antibody

49545-50ul 50ul
EUR 286.8

EGF antibody

70R-12248 100 ug
EUR 483.6
Description: Rabbit polyclonal EGF antibody

EGF antibody

70R-12249 100 ug
EUR 483.6
Description: Rabbit polyclonal EGF antibody

EGF antibody

70R-13940 100 ug
EUR 386.4
Description: Affinity purified Goat polyclonal EGF antibody

EGF antibody

70R-15294 100 ug
EUR 392.4
Description: Rabbit polyclonal EGF antibody

EGF antibody

70R-5697 50 ug
EUR 560.4
Description: Rabbit polyclonal EGF antibody

EGF Antibody

35720-100ul 100ul
EUR 302.4

EGF Antibody

5022-100 each
EUR 379.2

EGF Antibody

5022-30T each
EUR 175.2

EGF Antibody

5023R-100 each
EUR 379.2

EGF Antibody

5023R-30T each
EUR 175.2

EGF Antibody

ABD2225 100 ug
EUR 525.6

EGF Antibody

ABF5148 100 ug
EUR 525.6

EGF Antibody

ABD7063 100 ug
EUR 525.6

EGF Antibody

DF7063 200ul
EUR 420

EGF Antibody

DF2225 200ul
EUR 420

EGF Antibody

1-CSB-PA06244A0Rb
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EGF. Recognizes EGF from Human. This antibody is Unconjugated. Tested in the following application: ELISA

egf Antibody

1-CSB-PA24449A0Rb
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against egf. Recognizes egf from Zebrafish. This antibody is Unconjugated. Tested in the following application: ELISA, WB; Recommended dilution: WB:1:500-1:5000

EGF Antibody

1-CSB-PA846755
  • EUR 380.40
  • EUR 292.80
  • 100ul
  • 50ul
Description: A polyclonal antibody against EGF. Recognizes EGF from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100

EGF Antibody

1-CSB-PA942209
  • EUR 380.40
  • EUR 292.80
  • 100ul
  • 50ul
Description: A polyclonal antibody against EGF. Recognizes EGF from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:5000, IHC:1:50-1:200

EGF Antibody

1-CSB-PA007939
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EGF. Recognizes EGF from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/10000

EGF Antibody

F47084-0.08ML 0.08 ml
EUR 140.25
Description: This gene encodes a member of the epidermal growth factor superfamily. The encoded protein is synthesized as a large precursor molecule that is proteolytically cleaved to generate the 53-amino acid epidermal growth factor peptide. This protein acts a potent mitogenic factor that plays an important role in the growth, proliferation and differentiation of numerous cell types. This protein acts by binding the high affinity cell surface receptor, epidermal growth factor receptor. Defects in this gene are the cause of hypomagnesemia type 4. Dysregulation of this gene has been associated with the growth and progression of certain cancers. Alternate splicing results in multiple transcript variants.

EGF Antibody

F47084-0.4ML 0.4 ml
EUR 322.15
Description: This gene encodes a member of the epidermal growth factor superfamily. The encoded protein is synthesized as a large precursor molecule that is proteolytically cleaved to generate the 53-amino acid epidermal growth factor peptide. This protein acts a potent mitogenic factor that plays an important role in the growth, proliferation and differentiation of numerous cell types. This protein acts by binding the high affinity cell surface receptor, epidermal growth factor receptor. Defects in this gene are the cause of hypomagnesemia type 4. Dysregulation of this gene has been associated with the growth and progression of certain cancers. Alternate splicing results in multiple transcript variants.

EGF Antibody

R36053-100UG 100 ug
EUR 339.15
Description: Additional name(s) for this target protein: Epidermal growth factor

EGF Antibody

R30469 100 ug
EUR 356.15
Description: Epidermal growth factor(EGF) is a growth factor that plays an important role in the regulation of cell growth, proliferation and differentiation by binding to its receptor EGFR. EGF locus is mapped to 4q21-4qter. Human EGF is a 6045-Da protein with 53 amino acid residues and three intramolecular disulfide bones. EGF results in cellular proliferation, differentiation, and survival while plays an important physiological role in the maintenance of oro-esophageal and gastric tissue integrity.

EGF Antibody

R31863 100 ug
EUR 356.15
Description: EGF is known as epidermal growth factor. This gene encodes a member of the epidermal growth factor superfamily. The encoded preproprotein is proteolytically processed to generate the 53-amino acid epidermal growth factor peptide. This protein acts a potent mitogenic factor that plays an important role in the growth, proliferation and differentiation of numerous cell types. Additionally, it acts by binding with high affinity to the cell surface receptor, epidermal growth factor receptor. Defects in this gene are the cause of hypomagnesemia type 4. Dysregulation of this gene has been associated with the growth and progression of certain cancers. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed.

EGF Antibody

R31864 100 ug
EUR 356.15
Description: EGF is known as epidermal growth factor. This gene encodes a member of the epidermal growth factor superfamily. The encoded preproprotein is proteolytically processed to generate the 53-amino acid epidermal growth factor peptide. This protein acts a potent mitogenic factor that plays an important role in the growth, proliferation and differentiation of numerous cell types. Additionally, it acts by binding with high affinity to the cell surface receptor, epidermal growth factor receptor. Defects in this gene are the cause of hypomagnesemia type 4. Dysregulation of this gene has been associated with the growth and progression of certain cancers. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed.

HB-EGF/ Rat HB- EGF ELISA Kit

ELA-E1479r 96 Tests
EUR 1063.2

EGF GMP, CF

PR15112CF 200 ug
EUR 481.2

rHu EGF (cGMP)

AK9797-0040 40ug Ask for price

rec EGF (human)

H-7490.0100 0.1mg
EUR 194.4
Description: Sum Formula: C270H395N73O83S7; CAS# [62253-63-8]

rec EGF (human)

H-7490.0500 0.5mg
EUR 457.2
Description: Sum Formula: C270H395N73O83S7; CAS# [62253-63-8]

EGF Rabbit pAb

A12916-100ul 100 ul
EUR 369.6

EGF Rabbit pAb

A12916-200ul 200 ul
EUR 550.8

EGF Rabbit pAb

A12916-20ul 20 ul
EUR 219.6

EGF Rabbit pAb

A12916-50ul 50 ul
EUR 267.6

EGF Rabbit pAb

A13615-100ul 100 ul
EUR 369.6

EGF Rabbit pAb

A13615-200ul 200 ul
EUR 550.8

EGF Rabbit pAb

A13615-20ul 20 ul
EUR 219.6

EGF Rabbit pAb

A13615-50ul 50 ul
EUR 267.6

EGF Rabbit pAb

A2720-100ul 100 ul
EUR 369.6

EGF Rabbit pAb

A2720-200ul 200 ul
EUR 550.8

EGF Rabbit pAb

A2720-20ul 20 ul
EUR 219.6

EGF Rabbit pAb

A2720-50ul 50 ul
EUR 267.6

HB EGF Antibody

DF13666 100ul
EUR 420

EGF Protein (OVA)

20-abx165531
  • EUR 693.60
  • EUR 309.60
  • EUR 2064.00
  • EUR 828.00
  • EUR 510.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

EGF antibody (HRP)

61R-1022 100 ug
EUR 338.4
Description: Mouse monoclonal EGF antibody (HRP)

EGF antibody (HRP)

60R-1717 100 ug
EUR 392.4
Description: Rabbit polyclonal EGF antibody (HRP)

EGF (Rat) antibody

Y231 50 ul
EUR 512.4
Description: The EGF (Rat) antibody is available in Europe and for worldwide shipping via Gentaur.

EGF protein (Mouse)

30R-AE001 100 ug
EUR 152.4
Description: Purified recombinant Mouse EGF protein

Human EGF Protein

20-abx060144
  • EUR 292.80
  • EUR 518.40
  • 100 ug
  • 1 mg

EGF antibody (FITC)

60R-1718 100 ug
EUR 392.4
Description: Rabbit polyclonal EGF antibody (FITC)

Human EGF Protein

PROTP01133-2 500ug
EUR 380.4
Description: EGF is a potent growth factor that stimulates the proliferation of various epidermal and epithelial cells. Additionally, EGF has been shown to inhibit gastric secretion, and to be involved in wound healing. EGF signals through a receptor known as c-erbB, which is a class I tyrosine kinase receptor. This receptor also binds with TGF-α and VGF (vaccinia virus growth factor). Recombinant human EGF is a 6.2 kDa globular protein containing 53 amino acid residues including 3 intramolecular disulfide-bonds. .

*Animal-Free Human EGF (Catalog Number AF-100-15) has replaced Human EGF (Catalog Number 100-15)

EGF, carrier-free

PR15005CF 200 ug
EUR 248.4

EGF (Human) antibody

Y230 50 ul
EUR 512.4
Description: The EGF (Human) antibody is available in Europe and for worldwide shipping via Gentaur.

EGF cloning plasmid

CSB-CL007473HU-10ug 10ug
EUR 1536
Description: A cloning plasmid for the EGF gene.

EGF, rat recombinant

4024-100 each
EUR 364.8

EGF, rat recombinant

4024-1000 each
EUR 2173.2

EGF, rat recombinant

4024-20 each
EUR 192

EGF antibody (biotin)

60R-ER002bt 50 ug
EUR 571.2
Description: Rabbit polyclonal EGF antibody (biotin) conjugated

EGF antibody (biotin)

60R-1719 100 ug
EUR 392.4
Description: Rabbit polyclonal EGF antibody (biotin)

EGF Blocking Peptide

BF0066-BP 1mg
EUR 234

EGF Blocking Peptide

AF5148-BP 1mg
EUR 234

EGF Blocking Peptide

33R-4179 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of EGF antibody, catalog no. 70R-5697

EGF Blocking Peptide

DF7063-BP 1mg
EUR 234

EGF Blocking Peptide

DF2225-BP 1mg
EUR 234

EGF Receptor Antibody

F50598-0.4ML 0.4 ml
EUR 322.15
Description: The epidermal growth factor receptor is the cell-surface receptor for members of the epidermal growth factor family (EGF-family) of extracellular protein ligands. The epidermal growth factor receptor is a member of the ErbB family of receptors, a subfamily of four closely related receptor tyrosine kinases: EGFR (ErbB-1), HER2/c-neu (ErbB-2), Her 3 (ErbB-3) and Her 4 (ErbB-4). Mutations affecting EGFR expression or activity could result in cancer.

EGF Receptor Antibody

F40405-0.08ML 0.08 ml
EUR 140.25
Description: The protein encoded by this gene is a transmembrane glycoprotein that is a member of the protein kinase superfamily. This protein is a receptor for members of the epidermal growth factor family. EGFR is a cell surface protein that binds to epidermal growth factor. Binding of the protein to a ligand induces receptor dimerization and tyrosine autophosphorylation and leads to cell proliferation. Mutations in this gene are associated with lung cancer. Multiple alternatively spliced transcript variants that encode different protein isoforms have been found for this gene.

EGF Receptor Antibody

F40405-0.4ML 0.4 ml
EUR 330.65
Description: The protein encoded by this gene is a transmembrane glycoprotein that is a member of the protein kinase superfamily. This protein is a receptor for members of the epidermal growth factor family. EGFR is a cell surface protein that binds to epidermal growth factor. Binding of the protein to a ligand induces receptor dimerization and tyrosine autophosphorylation and leads to cell proliferation. Mutations in this gene are associated with lung cancer. Multiple alternatively spliced transcript variants that encode different protein isoforms have been found for this gene.

EGF Receptor Antibody

F40415-0.08ML 0.08 ml
EUR 140.25
Description: The protein encoded by this gene is a transmembrane glycoprotein that is a member of the protein kinase superfamily. This protein is a receptor for members of the epidermal growth factor family. EGFR is a cell surface protein that binds to epidermal growth factor. Binding of the protein to a ligand induces receptor dimerization and tyrosine autophosphorylation and leads to cell proliferation. Mutations in this gene are associated with lung cancer. Multiple alternatively spliced transcript variants that encode different protein isoforms have been found for this gene.

EGF Receptor Antibody

F49183-0.08ML 0.08 ml
EUR 140.25
Description: The protein encoded by this gene is a transmembrane glycoprotein that is a member of the protein kinase superfamily. This protein is a receptor for members of the epidermal growth factor family. EGFR is a cell surface protein that binds to epidermal growth factor. Binding of the protein to a ligand induces receptor dimerization and tyrosine autophosphorylation and leads to cell proliferation. Mutations in this gene are associated with lung cancer.

Recombinant Human EGF

SJA08-01 100µg/vial
EUR 168

EGF, murine recombinant

4023-100 each
EUR 164.4

EGF, murine recombinant

4023-1000 each
EUR 385.2

EGF, murine recombinant

4023-500 each
EUR 307.2

EGF, murine recombinant

4023-5000 each
EUR 1299.6

Polyclonal EGF Antibody

APR00243G 0.1mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human EGF . This antibody is tested and proven to work in the following applications:

Polyclonal EGF Antibody

APR00244G 0.1mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human EGF . This antibody is tested and proven to work in the following applications:

EGF Recombinant Protein

11-373 0.1 mg
EUR 651.3
Description: Human epidermal growth factor (EGF) is also known as HOMG4 and  URG,and is a growth factor that plays an important role in the regulation of cell growth, proliferation, and differentiation by binding to its receptor EGFR. Epidermal growth factor can be found in human platelets, macrophages, urine, saliva, milk, and plasma. EGF is the founding member of the EGF-family of proteins. Members of this protein family have highly similar structural and functional characteristics. All family members contain one or more repeats of the conserved amino acid sequence. The biological effects of salivary EGF include healing of oral and gastroesophageal ulcers, inhibition of gastric acid secretion, stimulation of DNA synthesis as well as mucosal protection from intraluminal injurious factors such as gastric acid, bile acids, pepsin, and trypsin and to physical, chemical and bacterial agents. Because of the increased risk of cancer by EGF, inhibiting it decreases cancer risk.

EGF Recombinant Protein

11-495 0.1 mg
EUR 651.3
Description: Human epidermal growth factor (EGF) is also known as HOMG4 and  URG,and is a growth factor that plays an important role in the regulation of cell growth, proliferation, and differentiation by binding to its receptor EGFR. Epidermal growth factor can be found in human platelets, macrophages, urine, saliva, milk, and plasma. EGF is the founding member of the EGF-family of proteins. Members of this protein family have highly similar structural and functional characteristics. All family members contain one or more repeats of the conserved amino acid sequence. The biological effects of salivary EGF include healing of oral and gastroesophageal ulcers, inhibition of gastric acid secretion, stimulation of DNA synthesis as well as mucosal protection from intraluminal injurious factors such as gastric acid, bile acids, pepsin, and trypsin and to physical, chemical and bacterial agents. Because of the increased risk of cancer by EGF, inhibiting it decreases cancer risk.

EGF Conjugated Antibody

C49545 100ul
EUR 476.4

In the present day, using synthetic intelligence for supporting this transition exhibits actual limitations in its implementation in operational follow, each on the stage of affected person care, but in addition within the basic each day lifetime of the well being skilled, due to the medico-legal imperatives induced by the guarantees of the ‘5P medication’.

On this paper, we suggest to fill this hole by introducing an authentic synthetic intelligence platform, named Maxwell, which follows an unsupervised studying method consistent with the medico-legal imperatives of the ‘5P medication’. We describe the useful platform traits and illustrate them by two examples of clustering in genomics and magnetic resonance imaging.